Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm

[1]  T. Ayer,et al.  Improved health outcomes from hepatitis C treatment scale-up in Spain’s prisons: A cost-effectiveness study , 2018 .

[2]  J. Lazarus,et al.  Micro-elimination - A path to global elimination of hepatitis C. , 2017, Journal of hepatology.

[3]  M. Buti,et al.  Effectiveness and safety of sofosbuvir‐based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real‐life cohort , 2017, Journal of viral hepatitis.

[4]  M. Mckee,et al.  Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees , 2016, The Lancet.

[5]  P. Vickerman,et al.  Is increased hepatitis C virus case‐finding combined with current or 8‐week to 12‐week direct‐acting antiviral therapy cost‐effective in UK prisons? A prevention benefit analysis , 2016, Hepatology.

[6]  A. d’Arminio Monforte,et al.  Hepatitis C management in prisons: An insight into daily clinical practice in three major Italian correctional houses , 2016, Hepatology.

[7]  J. Grefenstette,et al.  Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons , 2016, Annals of Internal Medicine.

[8]  O. Levina,et al.  High-risk behaviors after release from incarceration among people who inject drugs in St. Petersburg, Russia. , 2015, Drug and alcohol dependence.

[9]  A. Spaulding,et al.  Prisoners Treated for Hepatitis C with Protease Inhibitor, New York, USA, 2012 , 2015, Emerging infectious diseases.

[10]  M. Holodniy,et al.  Sofosbuvir-Based Treatment Regimens for Chronic, Genotype 1 Hepatitis C Virus Infection in U.S. Incarcerated Populations , 2014, Annals of Internal Medicine.

[11]  W. Chiu,et al.  Translational Research of Telecare for the Treatment of Hepatitis C , 2014, BioMed research international.

[12]  J. Rich,et al.  Responding to hepatitis C through the criminal justice system. , 2014, The New England journal of medicine.

[13]  T. Butler,et al.  Enhancing hepatitis C treatment in the custodial setting: a national roadmap , 2014, The Medical journal of Australia.

[14]  J. Rich,et al.  Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta‐analysis , 2013, Hepatology.

[15]  on behalf of the B14 Stop study group,et al.  Hepatitis C and B prevalence in Spanish prisons , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[16]  P. Haber,et al.  Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C , 2010, The Medical journal of Australia.

[17]  O. Gascuel,et al.  SeaView version 4: A multiplatform graphical user interface for sequence alignment and phylogenetic tree building. , 2010, Molecular biology and evolution.

[18]  Edward A Belongia,et al.  National Institutes of Health Consensus Development Conference Statement: management of hepatitis B. , 2009, Annals of internal medicine.

[19]  Sanjeev Arora,et al.  Project ECHO: Linking University Specialists with Rural and Prison-Based Clinicians to Improve Care for People with Chronic Hepatitis C in New Mexico , 2007, Public health reports.

[20]  X. Forns,et al.  Hepatitis C en España , 2006 .

[21]  J. Rich,et al.  Treatment of Chronic Hepatitis C in a State Correctional Facility , 2004, Annals of Internal Medicine.

[22]  J. Hoofnagle,et al.  National institutes of health consensus development conference statement: Management of hepatitis C: 2002 — June 10–12, 2002 , 2002, Gastroenterology.

[23]  S. Llerena,et al.  Prevalence of hepatitis C in the spanish population. The prevhep study (ethon cohort) , 2017 .

[24]  Sanjeev Arora,et al.  Treatment of chronic hepatitis C virus (HCV) infections with Direct Acting Antivirals in the New Mexico State Prison System using the Project ECHO Model , 2017 .

[25]  J. Pawlotsky,et al.  EASL Recommendations on Treatment of Hepatitis C 2016. , 2017, Journal of hepatology.

[26]  M. Blachier,et al.  Report Title: The burden of liver disease in Europe: a review of available epidemiological data , 2013 .

[27]  J. Sánchez‐Tapias.  Nosocomial transmission of hepatitis C virus. , 1999, Journal of hepatology.